Initially, we accumulated LJPC between $2.30 and $2.50 in November of 2019. The buying opportunity came after LJPC announced the discontinuation of its research and development program and the … [Read more...] about La Jolla Pharmaceuticals (Nasdaq: LJPC) Investment Update
Earnings
Verastem’s Earnings: Is It a Buy Now?
Verastem (VSTM) reported earnings on May 9th after the close of the American market and proceeded to plunge 28% during Friday's trading session. What was the cause of this selloff? Here are three big … [Read more...] about Verastem’s Earnings: Is It a Buy Now?
Biopharma Stock Watch May 13th-17th
The trade talks between the U.S. and Chinese officials have come and gone leaving no trade deal in place. While U.S markets were not rocked as hard as Asia's it was a still a relatively bloody week. … [Read more...] about Biopharma Stock Watch May 13th-17th
Earnings Alert: Eyepoint Pharmaceuticals and Alimera Sciences
On Wednesday, May 8th, Eyepoint Pharmaceuticals (EYPT) will be releasing its commercial and financial updates for the 1st quarter of 2019. Eyepoint is a commercial-stage specialty pharmaceuticals … [Read more...] about Earnings Alert: Eyepoint Pharmaceuticals and Alimera Sciences
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Portuguese
Russian
Spanish